Leucine metabolism in regulation of insulin secretion from pancreatic beta cells

Nutrition Reviews

Volumn 68, Issue 5, 2010, Pages 270-279

  Yang, Jichun ^a   Chi, Yujing ^a   Burkhardt, Brant R ^b   Guan, Youfei ^a   Wolf, Bryan A ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ATP synthase; Glutamate dehydrogenase; Leucine; MTOR

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLUTAMATE DEHYDROGENASE; INSULIN; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RAPAMYCIN;

AMINO ACID METABOLISM; APOPTOSIS; CELL FUNCTION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENZYMOLOGY; METABOLISM; SECRETION;

RODENTIA;

ANIMALS; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LEUCINE;

EID: 77955890920     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00282.x     Document Type: Review

References (115)

1. Stanley CA. Hyperinsulinism/hyperammonemia syndrome: Insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol Genet Metab. 2004;81(Suppl 1):45-51.
2. Sener A, Malaisse WJ. l-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature. 1980;288:187-189.
3. Liu YJ, Cheng H, Drought H, MacDonald MJ, Sharp GW, Straub SG. Activation of the KATP channel-independent signaling pathway by the nonhydrolyzable analog of leucine, BCH. Am J Physiol Endocrinol Metab. 2003;285:380-389.
4. Branstrom R, Efendic S, Berggren PO, Larsson O. Direct inhibition of the pancreatic beta-cell ATP-regulated potassium channel by alpha-ketoisocaproate. J Biol Chem. 1998;273: 14113-14118.
5. McDaniel ML, Marshall CA, Pappan KL, Kwon G. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic beta-cells. Diabetes. 2002;51:2877-2885.
6. Blomstrand E, Eliasson J, Karlsson HK, Kohnke R. Branchedchain amino acids activate key enzymes in protein synthesis after physical exercise. J Nutr. 2006;136(Suppl 1):S269-S273.
7. Stipanuk MH. Leucine and protein synthesis: MTOR and beyond. Nutr Rev. 2007;65:122-129.
8. Yoshizawa F. Regulation of protein synthesis by branchedchain amino acids in vivo. Biochem Biophys Res Commun. 2004;313:417-422.
9. Kwon G, Marshall CA, Pappan KL, Remedi MS, McDaniel ML. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes. 2004;53(Suppl 3):S225-S232.
10. Yang J, Wong RK, Wang X, et al. Leucine culture reveals that ATP synthase functions as a fuel sensor in pancreatic betacells. J Biol Chem. 2004;279:53915-53923.
11. Yang J, Wong RK, Park M, et al. Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic beta-cells. Diabetes. 2006;55: 193-201.
12. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes. 2007;56:1647-1654.
13. Nilsson M, Holst JJ, Bjorck IM. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: Studies using glucose-equivalent drinks. Am J Clin Nutr. 2007; 85:996-1004.
14. Rozance PJ, Limesand SW, Hay WW Jr. Decreased nutrientstimulated insulin secretion in chronically hypoglycemic late-gestation fetal sheep is due to an intrinsic islet defect. Am J Physiol Endocrinol Metab. 2006;291:404-411.
15. Kalogeropoulou D, Lafave L, Schweim K, Gannon MC, Nuttall FQ. Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose. Metabolism. 2008;57:1747-1752.
16. Parker B, Noakes M, Luscombe N, Clifton P. Effect of a highprotein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care. 2002;25:425-430.
17. Baum JI, Layman DK, Freund GG, Rahn KA, Nakamura MT, Yudell BE. A reduced carbohydrate, increased protein diet stabilizes glycemic control and minimizes adipose tissue glucose disposal in rats. J Nutr. 2006;136:1855-1861.
18. Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. 2006;136(Suppl 1):S319-S323.
19. Combaret L, Dardevet D, Rieu I, et al. A leucinesupplemented diet restores the defective postprandial inhibition of proteasome-dependent proteolysis in aged rat skeletal muscle. J Physiol. 2005;569:489-499.
20. Gao Z, Young RA, Li G, et al. Distinguishing features of leucine and alpha-ketoisocaproate sensing in pancreatic beta-cells. Endocrinology. 2003;144:1949-1957.
21. Smith TJ, Stanley CA. Untangling the glutamate dehydrogenase allosteric nightmare. Trends Biochem Sci. 2008;33: 557-564.
22. Henquin JC, Gembal M, Detimary P, Gao ZY, Warnotte C, Gilon P. Multisite control of insulin release by glucose. Diabete Metab. 1994;20:132-137.
23. Straub SG, Sharp GW. Inhibition of insulin secretion by cerulenin might be due to impaired glucose metabolism. Diabetes Metab Res Rev. 2007;23:146-151.
24. Macdonald MJ, Hasan NM, Longacre MJ. Studies with leucine, beta-hydroxybutyrate and ATP citrate lyasedeficient beta cells support the acetoacetate pathway of insulin secretion. Biochim Biophys Acta. 2008;1780:966-972.
25. Pongratz RL, Kibbey RG, Shulman GI, Cline GW. Cytosolic and mitochondrial malic enzyme isoforms differentially control insulin secretion. J Biol Chem. 2007;282:200-207.
26. Malaisse-Lagae F, Sener A, Garcia-Morales P, Valverde I, MalaisseWJ. The stimulus-secretion coupling of amino acidinduced insulin release. Influence of a nonmetabolized analog of leucine on the metabolism of glutamine in pancreatic islets. J Biol Chem. 1982;257:3754-3758.
27. Lenzen S, Formanek H, Panten U. Signal function of metabolism of neutral amino acids and 2-keto acids for initiation of insulin secretion. J Biol Chem. 1982;257:6631-6633.
28. Magge SN, Shyng SL, MacMullen C, et al. Familial leucinesensitive hypoglycemia of infancy due to a dominant mutation of the beta-cell sulfonylurea receptor. J Clin Endocrinol Metab. 2004;89:4450-4456.
29. Kelly A, Ng D, Ferry RJ Jr, et al. Acute insulin responses to leucine in children with the hyperinsulinism/ hyperammonemia syndrome. J Clin Endocrinol Metab. 2001;86:3724-3728.
30. Li C, Nissim I, Chen P, et al. Elimination of KATP channels in mouse islets results in elevated [U-13C] glucose metabolism, glutaminolysis, and pyruvate cycling but a decreased gamma-aminobutyric acid shunt. J Biol Chem. 2008;283: 17238-17249.
31. Ball AJ, Flatt PR, McClenaghan NH. Acute and long-term effects of nateglinide on insulin secretory pathways. Br J Pharmacol. 2004;142:367-373.
32. Rabaglia ME, Gray-Keller MP, Frey BL, Shortreed MR, Smith LM, Attie AD. Alpha-ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice. Am J Physiol Endocrinol Metab. 2005;289:E218-E224.
33. Konrad RJ, Jolly YC, Major C, Wolf BA. Fuel secretagogue stimulation of arachidonic acid accumulation in fresh and cultured pancreatic islets. Mol Cell Endocrinol. 1993;92:135-140.
34. Giroix MH, Saulnier C, Portha B. Decreased pancreatic islet response to l-leucine in the spontaneously diabetic GK rat: Enzymatic, metabolic and secretory data. Diabetologia. 1999;42:965-977.
35. MacDonald MJ. Synergistic potent insulin release by combinations ofweak secretagogues in pancreatic islets and INS-1 cells. J Biol Chem. 2007;282:6043-6052.
36. MacDonald MJ, Stoker SW, Hasan NM. Anaplerosis from glucose, alpha-ketoisocaproate, and pyruvate in pancreatic islets, INS-1 cells and liver mitochondria. Mol Cell Biochem. 2008;313:195-202.
37. Plaitakis A, Metaxari M, Shashidharan P. Nerve tissuespecific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: Implications for biologic function. J Neurochem. 2000;75:1862-1869.
38. De Leon DD, Stanley CA. Mechanisms of disease: Advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab. 2007;3:57-68.
39. Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998;338:1352-1357.
40. Gylfe E. Comparison of the effects of leucines, nonmetabolizable leucine analogues and other insulin secretagogues on the activity of glutamate dehydrogenase. Acta Diabetol Lat. 1976;13:20-24.
41. Li C, Allen A, Kwagh J, et al. Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem. 2006;281:10214-10221.
42. Yang SJ, Huh JW, Kim MJ, et al. Regulatory effects of 5'-deoxypyridoxal on glutamate dehydrogenase activity and insulin secretion in pancreatic islets. Biochimie. 2003;85:581-586.
43. Yang SJ, Huh JW, Lee JE, Choi SY, Kim TU, Cho SW. Inactivation of human glutamate dehydrogenase by aluminum. Cell Mol Life Sci. 2003;60:2538-2546.
44. Gao ZY, Li G, Najafi H, Wolf BA, Matschinsky FM. Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes. 1999;48:1535-1542.
45. Carobbio S, Ishihara H, Fernandez-Pascual S, Bartley C, Martin-Del-Rio R, Maechler P. Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets. Diabetologia. 2004;47:266-276.
46. Carobbio S, Frigerio F, Rubi B, et al. Deletion of glutamate dehydrogenase in beta-cells abolishes part of the insulin secretory response not required for glucose homeostasis. J Biol Chem. 2008;284:921-929.
47. Dekelbab BH, Sperling MA. Hyperinsulinemic hypoglycemia of infancy: The challenge continues. Diabetes Metab Res Rev. 2004;20:189-195.
48. Dekelbab BH, Sperling MA. Hypoglycemia in newborns and infants. Adv Pediatr. 2006;53:5-22.
49. Dekelbab BH, Sperling MA. Recent advances in hyperinsulinemic hypoglycemia of infancy. Acta Paediatr. 2006;95:1157-1164.
50. Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA. Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001;138:383-389.
51. MacMullen C, Fang J, Hsu BY, et al. Hyperinsulinism/ hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphatebinding domain of glutamate dehydrogenase. J Clin Endocrinol Metab. 2001;86:1782-1787.
52. Li C, Matter A, Kelly A, et al. Effects of a GTP-insensitive mutation of glutamate dehydrogenase on insulin secretion in transgenic mice. J Biol Chem. 2006;281:15064-15072.
53. Zaganas I, Spanaki C, Karpusas M, Plaitakis A. Substitution of Ser for Arg-443 in the regulatory domain of human housekeeping (GLUD1) glutamate dehydrogenase virtually abolishes basal activity and markedly alters the activation of the enzyme by ADP and l-leucine. J Biol Chem. 2002; 277:46552-46558.
54. Kapoor R, Flanagan S, Fulton P, et al. Hyperinsulinismhyperammonaemia (HI/HA) syndrome: Novel mutations in the GLUD1 gene and genotype-phenotype correlations. Eur J Endocrinol. 2009;161:731-735.
55. Li M, Allen A, Smith TJ. High throughput screening reveals several new classes of glutamate dehydrogenase inhibitors. Biochem. 2007;46:15089-15102.
56. Gustavsson N, Larsson-Nyren G, Lindstrom P. Pancreatic beta cells from db/db mice show cell-specific [Ca2+]i and NADH responses to glucose but not to alpha-ketoisocaproic acid. Pancreas. 2005;31:242-250.
57. Rideau N, Simon J. l-leucine or its keto acid potentiate but do not initiate insulin release in chicken. Am J Physiol. 1989;257:15-19.
58. Xu G, Kwon G, Cruz WS, Marshall CA, McDaniel ML. Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. Diabetes. 2001;50:353-360.
59. Xu G, Kwon G, Marshall CA, Lin TA, Lawrence JC Jr, McDaniel ML. Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. J Biol Chem. 1998;273:28178-28184.
60. Swenne I. Pancreatic beta-cell growth and diabetes mellitus. Diabetologia. 1992;35:193-201.
61. Swenne I, Borg LA, Crace CJ, Schnell Landstrom A. Persistent reduction of pancreatic beta-cell mass after a limited period of protein-energy malnutrition in the young rat. Diabetologia. 1992;35:939-945.
62. Gleason CE, Lu D,Witters LA, Newgard CB, Birnbaum MJ. The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. J Biol Chem. 2007;282:10341-10351.
63. Pruznak AM, Kazi AA, Frost RA, Vary TC, Lang CH. Activation of AMP-activated protein kinase by 5-aminoimidazole- 4-carboxamide-1-beta-D- ribonucleoside prevents leucinestimulated protein synthesis in rat skeletal muscle. J Nutr. 2008;138:1887-1894.
64. Fox HL, Kimball SR, Jefferson LS, Lynch CJ. Amino acids stimulate phosphorylation of p70S6k and organization of rat adipocytes into multicellular clusters. Am J Physiol. 1998;274:206-213.
65. Kimball SR, Horetsky RL, Jefferson LS. Implication of eIF2B rather than eIF4E in the regulation of global protein synthesis by amino acids in L6 myoblasts. J Biol Chem. 1998; 273:30945-30953.
66. Lynch CJ, Fox HL, Vary TC, Jefferson LS, Kimball SR. Regulation of amino acid-sensitive TOR signaling by leucine analogues in adipocytes. J Cell Biochem. 2000;77:234-251.
67. Pham PT, Heydrick SJ, Fox HL, Kimball SR, Jefferson LS Jr, Lynch CJ. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. J Cell Biochem. 2000;79:427-441.
68. Reiter AK, Anthony TG, Anthony JC, Jefferson LS, Kimball SR. ThemTOR signaling pathwaymediates control of ribosomal protein mRNA translation in rat liver. Int J Biochem Cell Biol. 2004;36:2169-2179.
69. Evans K, Nasim Z, Brown J, et al. Acidosis-sensing glutamine pump SNAT2 determines amino acid levels and mammalian target of rapamycin signalling to protein synthesis in L6 muscle cells. J Am Soc Nephrol. 2007;18:1426-1436.
70. Du M, Shen QW, Zhu MJ, Ford SP. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphateactivated protein kinase. J Anim Sci. 2007;85:919-927.
71. Dardevet D, Kimball SR, Jefferson LS, et al. Portal infusion of amino acids is more efficient than peripheral infusion in stimulating liver protein synthesis at the same hepatic amino acid load in dogs. Am J Clin Nutr. 2008;88:986-996.
72. Bell E, Cao X, Moibi JA, et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes. 2003;52:2731-2739.
73. Talvas J, Obled A, Fafournoux P, Mordier S. Regulation of protein synthesis by leucine starvation involves distinct mechanisms in mouse C2C12 myoblasts and myotubes. J Nutr. 2006;136:1466-1471.
74. Lee MY, Jo SD, Lee JH, Han HJ. l-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: Involvement of the PKC, PI3K/Akt, ERK1/2, andmTOR signaling pathways. J Cell Biochem. 2008;105:1410-1419.
75. Schliess F, Richter L, vom Dahl S, Haussinger D. Cell hydration and mTOR-dependent signalling. Acta Physiol. 2006;187:223-229.
76. Filiputti E, Ferreira F, Souza KL, et al. Impaired insulin secretion and decreased expression of the nutritionally responsive ribosomal kinase protein S6K-1 in pancreatic islets from malnourished rats. Life Sci. 2008;82:542-548.
77. Wang H, Iynedjian PB. Acute glucose intolerance in insulinoma cells with unbalanced overexpression of glucokinase. J Biol Chem. 1997;272:25731-25736.
78. Wang H, Iynedjian PB. Modulation of glucose responsiveness of insulinoma beta-cells by graded overexpression of glucokinase. Proc Natl Acad Sci U S A. 1997;94:4372-4377.
79. Antinozzi PA, Ishihara H, Newgard CB, Wollheim CB. Mitochondrial metabolism sets the maximal limit of fuelstimulated insulin secretion in a model pancreatic beta cell: A survey of four fuel secretagogues. J Biol Chem. 2002;277:11746-11755.
80. Anello M, Ucciardello V, Piro S, et al. Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP-to-ADP ratio. Am J Physiol Endocrinol Metab. 2001;281:1082-1087.
81. Zhang X, Sun N,Wang L, et al. AMP-activated protein kinase and pancreatic/duodenal homeobox-1 involved in insulin secretion under high leucine exposure in rat insulinoma beta-cells. J Cell Mol Med. 2009;13:758-770.
82. Martens GA, Cai Y, Hinke S, Stange G, Van de Casteele M, Pipeleers D. Glucose suppresses superoxide generation in metabolically responsive pancreatic beta cells. J Biol Chem. 2005;280:20389-20396.
83. Futai M, Noumi T, Maeda M. ATP synthase (H+-ATPase): Results by combined biochemical and molecular biological approaches. Annu Rev Biochem. 1989;58:111-136.
84. Mills DA, RichterML. Nucleotide binding to the isolated beta subunit of the chloroplast ATP synthase. J Biol Chem. 1991;266:7440-7444.
85. Boudina S, Sena S, Theobald H, et al.Mitochondrial energetics in the heart in obesity-related diabetes: Direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 2007;56:2457-2466.
86. Hojlund K, Wrzesinski K, Larsen PM, et al. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem. 2003;278:10436-10442.
87. Park M, Lin L, Thomas S, et al. The F1-ATPase beta-subunit is the putative enterostatin receptor. Peptides. 2004;25:2127-2133.
88. York DA, Lin L, Thomas SR, Braymer HD, Park M. Procolipase gene expression in the rat brain: Source of endogenous enterostatin production in the brain. Brain Res. 2006; 1087:52-59.
89. Lindqvist A, Berger K, Erlanson-Albertsson C. Enterostatin up-regulates the expression of the beta-subunit of F(1)F(o)- ATPase in the plasma membrane of INS-1 cells. Nutr Neurosci. 2008;11:55-60.
90. Silvestre RA, Rodriguez-Gallardo J, Marco J. Effect of enterostatin on insulin, glucagon, and somatostatin secretion in the perfused rat pancreas. Diabetes. 1996;45:1157-1160.
91. Ookuma M, York DA. Inhibition of insulin release by enterostatin. Int J Obes Relat Metab Disord. 1998;22:800-805.
92. Mei J, Bouras M, Erlanson-Albertsson C. Inhibition of insulin release by intraduodenally infused enterostatin-VPDPR in rats. Peptides. 1997;18:651-655.
93. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab. 2000;11:351-356.
94. Chan CB, Saleh MC, Koshkin V, Wheeler MB. Uncoupling protein 2 and islet function. Diabetes. 2004;53(Suppl 1): S136-S142.
95. Azzu V, Affourtit C, Breen EP, Parker N, Brand MD. Dynamic regulation of uncoupling protein 2 content in INS-1E insulinoma cells. Biochim Biophys Acta. 2008;1777:1378-1383.
96. Zhang CY, Baffy G, Perret P, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell. 2001;105:745-755.
97. Zhang CY, Parton LE, Ye CP, et al. Genipin inhibits UCP2- mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab. 2006;3:417-427.
98. Kohnke R, Mei J, Park M, York DA, Erlanson-Albertsson C. Fatty acids and glucose in high concentration downregulates ATP synthase beta-subunit protein expression in INS-1 cells. Nutr Neurosci. 2007;10:273-278.
99. Morgan NG. Fatty acids and beta-cell toxicity. Curr Opin Clin Nutr Metab Care. 2009;12:117-122.
100. Oprescu AI, Bikopoulos G, Naassan A, et al. Free fatty acidinduced reduction in glucose-stimulated insulin secretion: Evidence for a role of oxidative stress in vitro and in vivo. Diabetes. 2007;56:2927-2937.
101. Holohan C, Szegezdi E, Ritter T, O'Brien T, Samali A. Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. J Cell Mol Med. 2008;12:591-606.
102. Akerfeldt MC, Howes J, Chan JY, et al. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes. 2008;57:3034-3044.
103. Matschinsky FM. Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diab Rep. 2005;5:171-176.
104. Zelent D, Najafi H, Odili S, et al. Glucokinase and glucose homeostasis: Proven concepts and new ideas. Biochem Soc Trans. 2005;33:306-310.
105. Fridlyand LE, Philipson LH. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic beta-cells? Diabetes. 2004;53:1942-1948.
106. Produit-Zengaffinen N, Davis-Lameloise N, Perreten H, et al. Increasing uncoupling protein-2 in pancreatic beta cells does not alter glucose-induced insulin secretion but decreases production of reactive oxygen species. Diabetologia. 2007;50:84-93.
107. Wu L, Nicholson W, Knobel SM, et al. Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem. 2004;279:12126-12134.
108. Saitoh Y, Chun-ping C, Noma K, Ueno H, Mizuta M, Nakazato M. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells. Diabetes Obes Metab. 2008;10:564-573.
109. Ferre T, Riu E, Franckhauser S, Agudo J, Bosch F. Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia. 2003;46:1662-1668.
110. Kim JE, Kim YW, Lee IK, Kim JY, Kang YJ, Park SY. AMPactivated protein kinase activation by 5-aminoimidazole-4- carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression. J Pharmacol Sci. 2008;106:394-403.
111. Moibi JA, Gupta D, Jetton TL, Peshavaria M, Desai R, Leahy JL. Peroxisome proliferator-activated receptorgamma regulates expression of PDX-1 and NKX6.1 in INS-1 cells. Diabetes. 2007;56:88-95.
112. Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes. 2004;53(Suppl 3):S75-S78.
113. Kim SY, Kim HI, Park SK, et al. Liver glucokinase can be activated by peroxisome proliferator-activated receptorgamma. Diabetes. 2004;53(Suppl 1):S66-S70.
114. Kim HI, Ahn YH. Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cells. Diabetes. 2004;53(Suppl 1):S60-S65.
115. Choo HJ, Kim JH, Kwon OB, et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia. 2006;49:784-791.